NET PROFIT (x1000 SEK)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-6,588
|
-9,138
|
-14,832 |
| Total assets |
47,050
|
44,384
|
39,760 |
| Current assets |
26,144
|
24,132
|
20,071 |
| Current liabilities |
39,418
|
37,789
|
32,271 |
| Equity capital |
2,233
|
2,245
|
2,063 |
| - share capital |
4,466
|
4,489
|
4,126 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
4.7%
|
5.1%
|
5.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
66.3%
|
63.9%
|
62.2% |
| Return on equity (ROE) |
-295.0%
|
-407.0%
|
-719.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.